Causal Association Between Plasma Proteins and Pericarditis: A Mendelian Randomization Study With Therapeutic Target Identification
Related Experiment Video
Updated: Feb 13, 2026
Improving the Success Rate of Protein Crystallization by Random Microseed Matrix Screening
Published on: August 31, 2013
Zhexuan Chen1,2, Zongqiang Chen3, Lingfeng Peng1
1Department of Anesthesiology, Jieyang People's Hospital, No. 107 Tianfu Road Rongcheng District, Jieyang, 522000, Guangdong, China.
Insights
This study used Mendelian randomization to find 67 plasma proteins causally linked to pericarditis risk. Certain proteins increase risk, while others decrease it, offering potential therapeutic targets for pericarditis.
Area of Science:
- Cardiovascular Research
- Genetics
- Proteomics
Background:
- Observational studies suggest pro-inflammatory cytokines are key in pericarditis.
- A causal link between circulating plasma proteins and pericarditis remains unestablished.
Purpose of the Study:
- To assess the causal association between plasma proteins and pericarditis.
- To identify potential therapeutic targets for pericarditis.
Main Methods:
- Genome-wide association study (GWAS) in 35,559 individuals of European ancestry.
- Mendelian randomization (MR) analysis using 4907 plasma proteins as instrumental variables.
- Enrichment analyses, protein-protein interaction (PPI) network construction, and single-cell RNA sequencing (scRNA-seq).
- Molecular docking for drug target prediction.
Main Results:
- Identified 67 plasma proteins with potential causal relationships with pericarditis.
- Elevated NEU1, GDNF, and LAT increased pericarditis risk; higher CASP8, ZFYVE27, and NAPA decreased risk.
- scRNA-seq showed specific gene expression in cardiac progenitor cells (CPCs).
- Molecular docking identified potential anti-inflammatory compounds like melatonin.
Conclusions:
- MR analysis established causal links between plasma proteins and pericarditis.
- Identified potential therapeutic targets for pericarditis drug development.
- Findings support targeted drug development and clinical prevention strategies for pericarditis.
Background:
Observational studies demonstrate that pro-inflammatory cytokines play a critical role in pericarditis. However, the causal association between circulating plasma proteins and pericarditis remains unestablished.
Objective:
This research aimed to assess the causal association between plasma proteins and pericarditis and to investigate potential therapeutic targets.
Methods:
A genome-wide association study (GWAS) involving 35,559 individuals of European ancestry was conducted using 4907 plasma proteins as instrumental variables (IVs). The causal relationship between plasma proteins and pericarditis was examined using inverse weighted median, variance weighting, and Mendelian randomization (MR)-Egger methods. Horizontal pleiotropy was evaluated via MR-Egger regression, and heterogeneity was quantified by Cochran's Q statistic. In addition, enrichment analyses, construction of a protein-protein interaction (PPI) network, and single-cell RNA sequencing (scRNA-seq) analysis were performed. Molecular docking was used to predict potential drug targets.
Results:
MR analyses identified 67 plasma proteins with potential causal relationships with pericarditis, such as NEU1, GDNF, LAT, CASP8, ZFYVE27, and NAPA. Among them, elevated levels of NEU1, GDNF, and LAT increased the risk of pericarditis, whereas higher levels of CASP8, ZFYVE27, and NAPA decreased the risk of pericarditis. Pleiotropy tests and sensitivity analyses confirmed the stability of the findings. Moreover, scRNA-seq analysis revealed that genes such as extracellular matrix protein 1 (ECM1), CASP8, EPHA4, and CCL2 were specifically expressed in cardiac progenitor cells (CPCs). Molecular docking further identified compounds with anti-inflammatory, antioxidant, or immunomodulatory potential, including phorbol 12-myristate 13-acetate (PMA), cerivastatin, and melatonin.
Conclusion:
This research examined the causal association between plasma proteins and pericarditis by MR analysis and identified several potential therapeutic targets. These findings provide theoretical evidence for targeted drug development and clinical prevention strategies for pericarditis.
Related Concept Videos
01:22Pericarditis I: Introduction
01:21Causality in Epidemiology
01:29Pharmacogenomics: Identification of New Drug Targets
01:11Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
01:29Drug Distribution: Plasma Protein Binding